REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
17/11/2025
Voltar para busca
Dado oficial do USPTO
NEURIMMUNE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
68
Atualização mais recente
18/11/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42, 44
Data de depósito
03/03/2018
Data de registro
17/11/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/11/2020
Última transação
18/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
3
Tipo de titular
99
Localização do titular
Schlieren, CH
Examinador
HILL,JAMES T
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "NEURIMMUNE" above a design consisting of four lines. Two diagonal lines in opposite directions converge to become parallel horizontal lines. The diagonal portions of the lines are flanked by one additional diagonal parallel line each.
Titulares e representantes
Titulares
Neurimmune Holding AG
Representantes
Janice Housey
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
pharmaceutical preparations for treating diseases of the nervous systeminfectious diseasesneoplasmsdiseases of the immune systemendocrine and metabolic diseasesdiseases of the circulatory systemdiseases of the eye; veterinary preparations for treating diseases of the nervous systeminfectious diseasesneoplasmsdiseases of the immune systemendocrine and metabolic diseasesdiseases of the circulatory systemdiseases of the eye; pharmaceutical preparations for immunotherapeutic purposes; pharmaceutical agents for the removal of tumors; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparationsimmunogens; pharmaceutical preparationsantibodies for use in disease testing; vaccines; diagnostic preparations for medical purposes in the form of epitopes for detection of anomalies in proteins; pharmaceutical preparationssynthetic peptides for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; sanitary preparations for medical use; biological pharmaceutical and veterinary preparations for medical use being for the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; pharmaceutical and veterinary biocides; diagnostic preparations for medical and veterinary purposes; sanitary towels for hygiene purposes; dietetic foods adapted for medical use; dietetic beverages adapted for medical use; biological pharmaceutical and veterinary preparations in the nature of protein antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunologic diseasesinflammatory diseasesrespiratory diseasespsychological diseases for medical purposes; antibacterial pharmaceutical and veterinary preparationsantibacterial substances for medical purposesantibacterial pharmaceuticals; biopharmaceutical preparations for the treatment of cancer; protein dietary supplements
Classe 42
monitoringinspectionanalysis of biologically active chemical substances for quality control purposes; research on pharmaceutical productscosmetics and foodstuffs for others; consultancy and information services in the field of monitoring and inspection for the quality control and analysis of biologically active chemical substances; research in the field of medical treatment and methods; research in the fields of biotechnology and antibodies; medical and scientific research information in the field of clinical trial testing and research in medical treatment; research in the field of sanitary care; monitoring and inspection of biological synthesis and pharmaceutical manufacturing for quality control and scientific research purposes and research in the field of biology; computer software design; computer programming; maintenance of computer software; design and development of computer hardware; development of computer software; consultancy and provision of information relating to quality control of pharmaceutical preparations; scientific research in the field of cancerous diseases; scientific research relating to chemistry
Classe 44
medical services; medical services in the field of immunity; provision of medical information; medical examinationsphysical examination for medical purposes; preparation of medicinespharmaceutical compounding services and dispensing of medicines in the nature of pharmaceuticals; healthcare services in the nature of nutritional and dietary consultancy; consultancy and provision of information in the field of sanitary careproviding sanitary health care information; veterinary services; beauty salon services; care services for animalsveterinary care services; hygienic care; consultancy and provision of medical information relating to the operationpreparationadministration and dosage of pharmaceutical preparations; advisory services relating to pharmaceuticals; providing medical information to healthcare professionals and patients in the form of compiled medical reports in the field of diagnosticprophylactic and therapeutic properties of pharmaceuticals; drug use screening services for medical purposes; information services relating to health care
Publicações
Histórico de despachos e eventos da marca no USPTO.
68 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21/01/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/01/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
21/01/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/07/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/07/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
17/11/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/09/2020
PUBO
PUBLISHED FOR OPPOSITION
01/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/08/2020
CNEA
EXAMINERS AMENDMENT MAILED
27/07/2020
XAAP
EXAMINER'S AMENDMENT AFTER PUB APPROVAL
27/07/2020
OTHE
CASE RETURNED TO EXAMINATION
14/07/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
14/07/2020
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
02/07/2020
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
02/07/2020
APET
ASSIGNED TO PETITION STAFF
02/07/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/07/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/07/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
26/05/2020
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
26/05/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21/04/2020
EX3G
SOU EXTENSION 3 GRANTED
18/04/2020
EXT3
SOU EXTENSION 3 FILED
18/04/2020
EEXT
SOU TEAS EXTENSION RECEIVED
18/04/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/10/2019
EX2G
SOU EXTENSION 2 GRANTED
01/10/2019
EXT2
SOU EXTENSION 2 FILED
01/10/2019
EEXT
SOU TEAS EXTENSION RECEIVED
01/10/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/04/2019
EX1G
SOU EXTENSION 1 GRANTED
11/04/2019
EXT1
SOU EXTENSION 1 FILED
11/04/2019
EEXT
SOU TEAS EXTENSION RECEIVED
11/04/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
30/10/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2018
PUBO
PUBLISHED FOR OPPOSITION
04/09/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/08/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/07/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
27/07/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/07/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
27/07/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/07/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/07/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/07/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/07/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/06/2018
GNRT
NON-FINAL ACTION E-MAILED
22/06/2018
CNRT
NON-FINAL ACTION WRITTEN
22/06/2018
DOCK
ASSIGNED TO EXAMINER
15/06/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/03/2018
NWAP
NEW APPLICATION ENTERED
07/03/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEURIMMUNE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.